TABLE 2.
Role of exosomal miRNAs in breast cancer invasion, migration, and metastasis.
| Exosomal miRNA | Parameters | Molecular targets | Mechanism | References |
|---|---|---|---|---|
| miR-21, miR-10b, miR-373, miR-1246, miR-17-5p, miR-96, and miR-106b | Promotes invasion and migration | PTEN, PI3K, mapsin, PDCD4, HODX10, TBX5, DYRK1A, Syndecan-1, CCNG2, CD44, HBP1, TCF, LEF, ErbB2, FUT6, and Wnt/β-Catenin | ┬ Apoptosis, ┬ clone formation, ↑ Tumorigenesis, ↑ Migration, and regulates cytoskeleton and E-cadherin | Huang et al. (2008), Zhu et al. (2008), Li et al. (2011), Ibrahim et al. (2012), Chen et al. (2013), Eichelser et al. (2014), Singh et al. (2014), Feng and Tsao (2016), Hong et al. (2016), Kim et al. (2016), Li et al., 2016; Shi (2016), Li et al. (2017b), and Xu et al. (2019) |
| miR-564, miR-10a, miR-34c, miR-217, miR-1226-3p, miR-21, miR-19a-3p, miR-148b-3p, miR-19b, miR-1486-3p, miR-148a, miR-503, miR-17/20, and miR-100 | Suppresses invasion and migration | Akt, GNA12, GYS1, SRF, PIK/MAPK, mTOR, GIT1, KLF5, FZD8, Wnt-β-Catenin, AQP5, FOSL1, mucin1, TRIM29, CCND2/CCND3, E2F1, IL-8, and CCND1 | Arrest cell cycle, ↑ apoptosis, ↑ Intracellular adhesion, and ┬ cell survival and growth | Yu et al. (2010), Bovy et al. (2015), Jiang et al. (2016), Mutlu et al. (2016), Tao et al. (2016), Ke and Lou (2017), Zhou et al. (2017), Yuan et al. (2019), and Park et al. (2020) |
| miR-10b, miR-503, miR-122, miR-200, miR-105, and miR-21 | Promotes distant metastasis | β-Catenin, Twist, HOXD10, ROCK, c-Jun, XIST, STAT3, NF-ĸB, PD-L1, PKM, GLUT1, Sec23a, YAP1, ZO-1, LZTFL1, and EMT | ┬ Growth, ┬ Local immunity, ↑ EMT, motility, modulates cytoskeletal flexibility, and ↑ cell proliferation | Ma, 2010; Ma et al. (2010), Korpal et al. (2011), Liu et al. (2012), Yu et al. (2013), Zhou et al. (2014), Fong et al. (2015), Knirsh et al. (2016), Xing et al. (2018), and Wang et al. (2019) |
| miR-193a, miR-124-3p, miR-720, miR-31, miR-429, miR-124, and miR-1 | Suppresses distant metastasis | Wnt-β-Catenin, ZEB1, CRKL, CrKL, MMP-9, PDC D6, E-cadherin, Fzd3, Rho A, ITGA5, IL-11, Frizzled 7, TNKS2, BCL2, EGFR, WTL, TWISR1, HER2, Vimentin, and N-Cadherin | ┬ EMT, ┬ cell motility, ↑ apoptosis, and impair tumorigenesis | Barrett-Lee (2009), Lv et al. (2011), Li et al. (2013), Li et al. (2014), Liu et al. (2015), Ye et al. (2015), Xie et al. (2017), Cai et al. (2018), Zhang et al. (2018), Peng et al. (2020), and Zhang et al. (2020) |
| miR-22, miR-221/222, miR-143, miR-21, and miR-378e | Promotes stemness | TET, PTEN, Akt, NF-ĸB, COX-2, Sox2, Oct3/4, nanog, Zeb, and Snail | ↑ Stemness biomarkers, ↑EMT, and induces clonal expansion | Song et al. (2013), Li et al. (2017a), and Donnarumma et al. (2017) |
| miR-34a and miR-140 | Suppresses stemness | NOTCH1, Sox2, Sox9 | ┬ Stem cells, modulate stem cell renewal, and shrink stem cells | Park et al. (2014), Wolfson et al. (2014), Kim et al. (2016) |
| miR-155 and miR-132 | Promotes angiogenesis | VHL/HIF, RAS, and VEGF | ↓ Pro-angiogenetic substrates | Kong et al. (2014) and Kontomanolis et al. (2017) |
| miR-16, miR-503, and miR-100 | Suppress angiogenesis | VEGF, FGF2, VEGFA, mtor, and HIF-1α | Modulate expression of pro-angiogenic molecules and ┬ angiogenesis | Lee et al. (2013), Zhou et al. (2013), and Pakravan et al. (2017) |
↑- Increase/upregulation; ↓- Decrease/Downregulation; ┴- Inhibit/Prevent.